Zaheer‐Ud‐Din Babar

Researcher Next ID · RN-030483

Researcher · Economics, Econometrics and Finance

The Hague, Qatar

Not currently recruitingFunding unknown

Research interests

Economics, Econometrics and Finance

Medicine

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutics

Pharmaceutical Economics and Policy

Pharmaceutical Practices and Patient Outcomes

Health Systems, Economic Evaluations, Quality of Life

Antibiotic Use and Resistance

Pharmaceutical industry and healthcare

Hearing loss prevalence and years lived with disability, 1990–2019: findings from the Global Burden of Disease Study 2019
The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(21)00516-x
Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019
The Lancet Infectious Diseases · 2021 · https://doi.org/10.1016/s1473-3099(21)00449-7
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1
The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(21)00984-3
Drug Shortage: Causes, Impact, and Mitigation Strategies
Frontiers in Pharmacology · 2021 · https://doi.org/10.3389/fphar.2021.693426
Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis
Scientific Reports · 2020 · https://doi.org/10.1038/s41598-020-62795-1
How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries
Applied Health Economics and Health Policy · 2017 · https://doi.org/10.1007/s40258-016-0300-z
Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study
The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)00449-0

No projects listed.